Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Cyanoacrylate injection versus band ligation for bleeding from cardiac varices along the lesser curvature of the stomach

Sang Jung Park, Yong Kwon Kim, Yeon Seok Seo, Seung Woon Park, Han Ah Lee, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jae Young Jang, Jong Eun Yeon, Kwan Soo Byun

Clin Mol Hepatol. 2016;22(4):487-494. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0050

View: 8799 Download: 150 Web of Science: 10 Crossref: 9

3

Effect of Endoscopic Sclerotherapy Using N-butyl-2-cyanoacrylate in Patients with Gastric Variceal Bleeding

Jae Woo Kim , Soon Koo Baik , Kyu Hong Kim , Hye Jeong Kim , Ki Won Jo , Jin Hon Hong , Myeong Gwan Jee , Hyun Soo Kim , Sang Ok Kwon

Clin Mol Hepatol. 2006;12(3):394-403. Published online January 1, 2000

View: 2457 Download: 27

N-Butyl-2-Cyanoacrylate (Histoacryl) in the Treatment of Esophageal Variceal Bleeding ; Comparison with Band Ligation

Gyu Hyun Lee, M.D., Yong Jun Shin, M.D, Young Yun Ko, M.D. Jun Ho Ko, M.D., Ho Dong Kim, M.D., Byeong Moo Yoo, M.D. Kwang Jae Lee, M.D., Young Soo Kim, M.D., Ki Baik Hahm, M.D. Jin Hong Kim, M.D. and Sung Won Cho, M.D.

Clin Mol Hepatol. 1999;5(4):306-313. Published online January 1, 2000

View: 2134 Download: 16

1 |

Viewed By 5162	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5017	MAFLD: How is it different from NAFLD?
Viewed By 4926	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3643	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3591	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 67	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search